mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-07 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.009 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.08 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-08 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-10 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.03 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
9e-05 |